Patents Assigned to Genus Oncology, LLC
  • MUC-1 cytoplasmic domain peptides as inhibitors of cancer
    Patent number: 8524669
    Abstract: The invention provides for peptides from the Mucin 1 (MUC1) cytoplasmic domain and methods of use therefor. These peptides can inhibit MUC1 oligomerization, thereby preventing tumor cell growth, inducing tumor cell apoptosis and necrosis of tumor tissue in vivo.
    Type: Grant
    Filed: October 16, 2009
    Date of Patent: September 3, 2013
    Assignees: Dana-Farber Cancer Institute, Inc., Genus Oncology, LLC
    Inventors: Donald W. Kufe, Surender Kharbanda